Table 1. Relationship between HALP score and clinical pathology of EC patients.
| Clinical data | n | HALP score | Statistic | P | |
|---|---|---|---|---|---|
| >22.2 (n = 43) | ≤22.2 (n = 115) | ||||
| Age | |||||
| <60 years | 98 | 26 | 72 | 0.247 | 0.805 |
| ≥60 years | 60 | 17 | 43 | ||
| Menopause | |||||
| No | 57 | 20 | 37 | 1.670 | 0.095 |
| Yes | 101 | 23 | 78 | ||
| Stage | |||||
| Stage I | 114 | 31 | 83 | 1.827 | 0.609 |
| Stage II | 16 | 6 | 10 | ||
| Stage III | 26 | 6 | 20 | ||
| Stage IV | 2 | 0 | 2 | ||
| Differentiation | |||||
| High | 66 | 28 | 38 | 15.372 | 0.001 |
| Moderate | 61 | 7 | 54 | ||
| Low | 31 | 8 | 23 | ||
| Depth of myometrial invasion | |||||
| <1/2 | 109 | 36 | 73 | 2.448 | 0.014 |
| ≥1/2 | 49 | 7 | 42 | ||
| Lymph node metastasis | |||||
| No | 137 | 42 | 95 | 2.483 | 0.013 |
| Yes | 21 | 1 | 20 | ||